Low-power laser irradiation inhibits arecoline-induced fibrosis: an in vitro study

Mei-Chun Yeh , Ker-Kong Chen , Min-Hsuan Chiang , Chia-Hsin Chen , Ping-Ho Chen , Huey-Er Lee , Yan-Hsiung Wang

International Journal of Oral Science ›› 2017, Vol. 9 ›› Issue (1) : 38 -42.

PDF
International Journal of Oral Science ›› 2017, Vol. 9 ›› Issue (1) : 38 -42. DOI: 10.1038/ijos.2016.49
Article

Low-power laser irradiation inhibits arecoline-induced fibrosis: an in vitro study

Author information +
History +
PDF

Abstract

Low-power laser irradiation (LPLI) could treat a debilitating pre-malignant, fibrotic condition of the mouth. Most cases of oral submucous fibrosis (OSF) are in South Asia and are associated with areca nut chewing. The compound arecoline in the nut is thought to be involved in its development. Yan-Hsiung Wang, Huey-Er Lee and colleagues of Taiwan’s Kaohsiung Medical University tested the effects of LPLI on fibroblasts, cells producing connective tissue, from the human gum, which they stimulated with arecoline. Applying LPLI can activate a key cell-regulating enzyme, adenylyl cyclase, reduced the expression of fibrosis-related genes. LPLI’s effect was blocked when the cells were pretreated with an adenylyl cyclase inhibitor. LPLI may inhibit the effects of arecoline via adenylyl cyclase and could be used as an antifibrotic therapy in the future.

Keywords

adenylate cyclase / alpha-smooth muscle actin / connective tissue growth factor / fibrosis / low-power laser irradiation

Cite this article

Download citation ▾
Mei-Chun Yeh, Ker-Kong Chen, Min-Hsuan Chiang, Chia-Hsin Chen, Ping-Ho Chen, Huey-Er Lee, Yan-Hsiung Wang. Low-power laser irradiation inhibits arecoline-induced fibrosis: an in vitro study. International Journal of Oral Science, 2017, 9(1): 38-42 DOI:10.1038/ijos.2016.49

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Prabhu RV, Prabhu V, Chatra L. Areca nut and its role in oral submucous fibrosis. J Clin Exp Dent, 2014, 6(5): e569-e575.

[2]

Chole RH, Gondivkar SM, Gadbail AR. Review of drug treatment of oral submucous fibrosis. Oral Oncol, 2012, 48(5): 393-398.

[3]

Yoithapprabhunath TR, Maheswaran T, Dineshshankar J. Pathogenesis and therapeutic intervention of oral submucous fibrosis. J Pharm Bioallied Sci, 2013, 5(Suppl 1): S85-S88.

[4]

Arakeri G, Brennan PA. Oral submucous fibrosis: an overview of the aetiology, pathogenesis, classification, and principles of management. Br J Oral Maxillofac Surg, 2013, 51(7): 587-593.

[5]

Khan S, Chatra L, Prashanth SK. Pathogenesis of oral submucous fibrosis. J Cancer Res Ther, 2012, 8(2): 199-203.

[6]

Thangjam GS, Agarwal P, Balapure AK. Regulation of extracellular matrix genes by arecoline in primary gingival fibroblasts requires epithelial factors. J Periodontal Res, 2009, 44(6): 736-743.

[7]

Rajalalitha P, Vali S. Molecular pathogenesis of oral submucous fibrosis-a collagen metabolic disorder. J Oral Pathol Med, 2005, 34(6): 321-328.

[8]

Rockey DC, Bell PD, Hill JA. Fibrosis-a common pathway to organ injury and failure. N Engl J Med, 2015, 372(12): 1138-1149.

[9]

Finnson KW, Arany PR, Philip A. Transforming growth factor beta signaling in cutaneous wound healing: lessons learned from animal studies. Adv Wound Care (New Rochelle), 2013, 2(5): 225-237.

[10]

Insel PA, Murray F, Yokoyama U. cAMP and Epac in the regulation of tissue fibrosis. Br J Pharmacol, 2012, 166(2): 447-456.

[11]

Xu SW, Leask A, Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev, 2008, 19(2): 133-144.

[12]

Huang G, Brigstock DR. Regulation of hepatic stellate cells by connective tissue growth factor. Front Biosci (Landmark Ed), 2012, 17: 2495-2507.

[13]

Leask A, Sa S, Holmes A. The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Mol Pathol, 2001, 54(3): 180-183.

[14]

Allen JT, Knight RA, Bloor CA. Enhanced insulin-like growth factor binding protein-related protein 2 (Connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Cell Mol Biol, 1999, 21(6): 693-700.

[15]

Paradis V, Dargere D, Vidaud M. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology, 1999, 30(4): 968-976.

[16]

Ito Y, Aten J, Bende RJ, Oemar BS. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int, 1998, 53(4): 853-861.

[17]

Kantarci A, Black SA, Xydas CE. Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis. J Pathol, 2006, 210(1): 59-66.

[18]

Wu JY, Chen CH, Wang CZ. Low-power laser irradiation suppresses inflammatory response of human adipose-derived stem cells by modulating intracellular cyclic AMP level and NF-κB activity. PLoS One, 2013, 8(1): e54067.

[19]

Gal P, Mokry M, Vidinsky B. Effect of equal daily doses achieved by different power densities of low-level laser therapy at 635 nm on open skin wound healing in normal and corticosteroid-treated rats. Lasers Med Sci, 2009, 24(4): 539-547.

[20]

Sakurai Y, Yamaguchi M, Abiko Y. Inhibitory effect of low-level laser irradiation on LPS-stimulated prostaglandin E2 production and cyclooxygenase-2 in human gingival fibroblasts. Eur J Oral Sci, 2000, 108(1): 29-34.

[21]

Fillipin LI, Mauriz JL, Vedovelli K. Low-level laser therapy (LLLT) prevents oxidative stress and reduces fibrosis in rat traumatized Achilles tendon. Lasers Surg Med, 2005, 37(4): 293-300.

[22]

Oliveira FA, Moraes AC, Paiva AP. Low-level laser therapy decreases renal interstitial fibrosis. Photomed Laser Surg, 2012, 30(12): 705-713.

[23]

Alves AN, Fernandes KP, Melo CA. Modulating effect of low level-laser therapy on fibrosis in the repair process of the tibialis anterior muscle in rats. Lasers Med Sci, 2014, 29(2): 813-821.

[24]

Hillmann G, Steinkamp-Zucht A, Geurtsen W. Culture of primary human gingival fibroblasts on biodegradable membranes. Biomaterials, 2002, 23(6): 1461-1469.

[25]

Eguchi T, Kubota S, Kawata K. Different transcriptional strategies for ccn2/ctgf gene induction between human chondrocytic and breast cancer cell lines. Biochimie, 2007, 89(3): 278-288.

[26]

Black SA Jr., Palamakumbura AH, Stan M. Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c-JUN N-terminal kinase. J Biol Chem, 2007, 282(21): 15416-15429.

[27]

Schiller M, Dennler S, Anderegg U. Increased cAMP levels modulate transforming growth factor-beta(TGF-β)/Smad-induced expression of extracellular matrix components and other key fibroblast effector functions. J Biol Chem, 2010, 285(1): 409-421.

[28]

Swaney JS, Roth DM, Olson ER. Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc Natl Acad Sci USA, 2005, 102(2): 437-442.

[29]

Huang SK, Wettlaufer SH, Chung J. Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1. Am J Respir Cell Mol Biol, 2008, 39(4): 482-489.

[30]

Wu JY, Chen CH, Yeh LY et al. Low-power laser irradiation promotes the proliferation and osteogenic differentiation of human periodontal ligament cells via cyclic adenosine monophosphate. Int J Oral Sci 5 (2): 85–91.

AI Summary AI Mindmap
PDF

145

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/